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Abstract
Background: Acute myeloid leukemia (AML) 1-Evi-1 is a chimeric gene generated by the t (3; 21) (q26; q22)
translocation, which leads into malignant transformation of hematopoietic stem cells by unclear mechanisms. This
in vivo study aimed to establish a stable line of zebrafish expressing the human RUNX1-Evi-1 fusion gene under the
control of a heat stress-inducible bidirectional promoter, and investigate its roles in hematopoiesis and hematologic
malignancies.
Methods: We introduced human RUNX1-Evi-1 fusion gene into embryonic zebrafish through a heat-shock
promoter to establish Tg(RE:HSE:EGFP) zebrafish. Two males and one female mosaic F0 zebrafish embryos (2.1 %)
were identified as stable positive germline transgenic zebrafish.
Results: The population of immature myeloid cells and hematopoietic blast cells were accumulated in peripheral
blood and single cell suspension from kidney of adult Tg(RE:HSE:EGFP) zebrafish. RUNX1-Evi-1 presented an
intensive influence on hematopoietic regulatory factors. Consequently, primitive hematopoiesis was enhanced by
upregulation of gata2 and scl, while erythropoiesis was downregulated due to the suppression of gata1. Early stage
of myelopoiesis was flourishing with the high expression of pu.1, but it was inhibited along with the low expression
of mpo. Microarray analysis demonstrated that RUNX1-Evi-1 not only upregulated proteasome, cell cycle, glycolysis/
gluconeogenesis, tyrosine metabolism, drug metabolism, and PPAR pathway, but also suppressed transforming
growth factor β, Jak-STAT, DNA replication, mismatch repair, p53 pathway, JNK signaling pathway, and nucleotide
excision repair. Interestingly, histone deacetylase 4 was significantly up-regulated. Factors in cell proliferation were
obviously suppressed after 3-day treatment with histone deacetylase inhibitor, valproic acid. Accordingly, higher
proportion of G1 arrest and apoptosis were manifested by the propidium iodide staining.
Conclusion: RUNX1-Evi-1 may promote proliferation and apoptosis resistance of primitive hematopoietic cell, and
inhibit the differentiation of myeloid cells with the synergy of different pathways and factors. VPA may be a
promising choice in the molecular targeting therapy of RUNX1-Evi-1-related leukemia.
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Background
RUNX1-Ecotropic viral integration site (Evi)-1 chimeric
gene is generated by the t(3;21)(q26;q22) translocation
and plays a pivotal role in progression of different
hematopoietic stem cell malignancies [myelodysplastic
syndrome (MDS), chronic myelogenous leukemia to acute
blastic crisis phase, and acute myelogenous leukemia
(AML)]. RUNX1, also named AML1, is essential for
hematopoietic cell development in fetal liver as well as
lineage-specific differentiation in adult liver. Point
mutations of RUNX1 are relatively common in M0AML
(12-33 %), MDS (23 %), and therapy-related and radiation-
associated MDS/AML (38-46 %) [1]. Evi-1 is a nuclear
transcription factor that plays an essential role in the regu-
lation of hematopoietic stem cells. Aberrant expression of
Evi-1 has been reported in up to 10 % of patients with
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AML, which can predict poor outcome as a diagnostic
marker [2]. However, bone marrow cells of murine trans-
duced with Evi-1 alone cannot cause leukemia [3], while
deletion of RUNX1 alone does not immortalize bone
marrow cells [4], which suggest that both suppression of
RUNX1 and activation of Evi-1 are required for
RUNX1-Evi-1 leukemogenesis. It could be assumed
that RUNX1-Evi-1 shares several molecular processes
with wild-type Evi-1 and RUNX1 is more widely expressed
in hematopoietic cells than Evi-1, it causes activation of
Evi-1 function in hematopoietic cells, thus enhance cellu-
lar proliferation.
Evi-1 protein has two separate Cys2His2-type zinc
finger domains. In RUNX1-Evi-1 chimeric protein, the
N-terminal half of RUNX1 including a runt homology
domain (RHD) is fused to the entire zinc-finger Evi-1
(Fig. 1). Takeshita et al. demonstrated that the entire
sequence of Evi-1 was required for transformation of
primary bone marrow leukemia cells by RUNX1-Evi-1
[5]. Mice transplanted with RUNX1-Evi-1 retroviral
transduced bone marrow cells suffered from an AML
5–13 mo after transplantation. The disease could be
readily transferred into secondary recipients with a much
shorter latency [6]. In another distinct BMT mouse model,
Evi-1 seemed to collaborate with an RUNX1 mutant har-
boring a point mutation in the Runt homology domain
(D171N) to induce with an identical phenotype character-
ized by marked hepatosplenomegaly, myeloid dysplasia,
leukocytosis, and biphenotypic surface markers [7]. How-
ever, all of these sick mice died soon after transplantation,
and generation of transgenic offspring to carry on the
follow-up study is impossible.
Zebrafish (Danio rerio) hematopoiesis shows anatomic,
physiologic, and genetic conservation with that of humans
[8]. Furthermore, ectopic expression of human or murine
oncogenes driven by specific promoters in zebrafish has
been shown to faithfully develop leukemia closely parallel
to the human leukemia subtypes [9]. Finally, the efficient
reproduction and rapid development of zebrafish embryos
allow it to become a convenient model to investigate
tumor development and dissemination in real time even
without sacrificing the animals.
In this study, we established a stable line of zebrafish
expressing the human RUNX1-Evi-1 fusion gene under
the control of a heat stress-inducible bidirectional pro-
moter to examine its roles in hematopoiesis and hema-
tologic malignancies. Interestingly, the phenotypes of
these fish resembled to those of the human’s MDS-RAEB
or AML. This transgenic strategy was based on previous
studies [6, 10].
Methods
This study was approved by the Institutional Animal
Care and Use Committee (IACUC) of Shanghai Research
Center for Model Organisms in China (approved ID:
2010–0010).
Plasmid construction
The cDNA of human AML1(RUNX1)-Evi-1 was identified
and obtained from the SKH-1 cell line and inserted into
the EcoRI site of pME18S, named as pME-AE (generous
gift from Motohi Ichikawa) [5]. It was subcloned into
EcoRI and EcoRV (Takara, Japan) sites of the pSGH2
vector [10], which contains eight HSE sequence (AGAAC
GTTCTAGAAC) and EGFP segment. Then, we obtain the
hRUNX1-Evi-1-HSE-EGFP insert construct (Fig. 2a), HSE
allows the symmetrical addition of a CMV minimal pro-
moter to both ends in order to drive the expression of two
interested genes (EGFP at one side and hRUNX1-Evi-1 at
the other side) flanked by 5 V and 3 V globin UTRs and
SV40 polyadenylation (pA) signal (I-SceI meganuclease
recognition sites) (Fig. 2b).
Generation of the Tg(RE:HSE:EGFP) zebrafish line
Zebrafish was maintained as described by Westerfield
[11]. Developmental stages refer to hours or days post
Fig. 1 Schematic structure of wild-type RUNX1, Evi-1 and RUNX1/Evi-1 [30]. Wild-type RUNX1 possesses RHD at the N-terminus and PST region at
the C-terminus. In RUNX1/Evi-1, N-terminal RUNX1 sequences are abruptly interrupted at the end of the RHD and followed by almost the entire
coding region of Evi-1, including Evi-1 noncoding region, the first zinc finger domain, the second zinc finger domain, and an acidic (acidic amino
acid-rich) domain are shown by boxes
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fertilization (hpf or dpf). Fertilized wild type (WT) AB
fish eggs were microinjected through the chorion into
the cytoplasm at the one-cell stage of development
according to our previous work [12]. The pSGH2-
hRUNX1-Evi-1 plasmid was co-injected with I-SceI
meganuclease enzyme (0.5 units/μL) (New England
Bio Labs). A pressure injector (IM-300, NARISHIGE)
was used with borosilicate glass capillaries. After injection,
the embryos were collected in Petri dishes and incubated
at 28 °C. Heat shock was executed at 38 °C for 1 hour at
between 14 to 18 hpf to induce EGFP and RUNX1-Evi-1
expression. EGFP+ fish were screened under the fluores-
cent microscope on the next day and bred up to sexual
maturity, then crossed with the WT AB fish. The transge-
netic (Tg) offspring also received heat shock for an hour
to induce the target genes expression.
Real-time quantitative reverse transcription PCR
(qRT-PCR) and western blot analysis
QRT-PCR was performed as described previously [11]. It
was performed using 400 ng of cDNA templates in an
ABI StepOnePlus System (Applied Biosystems, USA).
PCR primers were designed to span introns and listed in
Table 1. Measured cycle threshold (Ct) values represent
log2 expression levels. Each target gene was normalized
to β–actin and calculated using the 2-ΔΔCT method [13].
Deyolking embryos and protein immunoblotting were
performed as described [14]. Anti-JNK (No.9252) and
anti-actin antibodies were purchased from Cell Signaling
Technology (Beverly, MA). Anti-p-JNK (No.sc-12882) was
purchased from Santa Cruz Biotech (USA).
In situ hybridization
Whole-mount in situ hybridization was performed with
digoxigenin-labeled (Roche) antisense riboprobes for
hematopoietic transcription factors (scl, lmo2, gata1, pu.1,
mpo) according to our previous work [15].
Cytological analysis
After transferred into 50 mg/L tricaine for 1 ~ 3 min,
blood was harvested from zebrafish by making a lateral
incision just posterior to the dorsal fin in the dorsal
aorta area and used in preparing blood smears [16].
Slides were then stained with Wright Giemsa stain and
examined under oil immersion by light microscopy.
Identification of zebrafish peripheral blood cells was
based, in part, on previous descriptions of teleost blood
cells [17]. Single cell suspensions of kidney were collected
and filtered by 40 μm mesh, than stained by the same
method.
Microarray analysis
The WT and Tg(RE:HSE:EGFP) F2 generation embryos
were heated shocked at 38 °C for 1 hour at 16 hpf, then
raised to 3 dpf. Total RNAs were isolated with Trizol
(Invitrogen). The samples were processed and subse-
quently analyzed in triplicate on Zebrafish Oligo Microar-
rays (Agilent Technologies Italia, Italy) which contain
Fig. 2 Generation of Tg(RE:HSE:EGFP) zebrafish line. (a) Schematic diagram of the structure of PSGH2/RUNX1-Evi-1 recombinant plasmid. A
human-RUNX1-Evi-1 fragment was cloned into the EcoRI and EcoRV sites of the PSGH2 vector. (b) A schematic presentation of the eight multimerized
heat shock element (HSE) promoter, which is flanked by two minimal promoters in opposed orientation (black arrowhead) to bidirectionally induce
EGFP and RUNX1-Evi-1 expression. The vector is flanked by I-SceI meganuclease sites (arrows). pA, SV40 polyadenylation signal. (c) Transgenic
verification by PCR: M: TAKARA DL2000 marker; lane 1 and 2: wild type and Tg(RE:HSE:EGFP) zebrafish larvae at 3 dpf, respectively; lane 3: PSGH2/
RUNX1-Evi-1 plasmid; lane 4: double distilled water. (d) EGFP expression in Tg(RE:HSE:EGFP) zebrafish F2 generation at 3dpf (×4)
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43,554 sets of probes. The microarrays were scanned in an
Agilent DNA Microarray Scanner and the images were
processed using Feature Extraction software. Functional
annotation analysis was performed using NIH-DAVID
software (version 6.7) to find the most relevant Kyoto
Encyclopedia of Genes and Genomes (KEGG) terms asso-
ciated with differentially expressed genes (DEGs) [18]. For
this purpose, the significance p-value threshold was set as
<0.01, with Bonferroni multiple testing correction (<0.01).
Drug administration
Valproic acid (VPA, CAS Number: 1069-66-5, Sigma-
Aldrich Co. LLC., USA) was dissolved with DMSO and
then diluted into different concentrations of 5, 10, 25,
50, 100, 250, 500 μM (DMSO < 0.2 % in each to avoid
the toxicity of DMSO [19]) in egg water. 30 embryos
were maintained in individual wells in 12-well microtitre
plates at 28 °C from 14 hpf. At 24 and 48 hr after VPA
treatment, larvae were collected for LD50 confirmation
and gene screen.
FACS profile analysis
Tg(RE:HSE:EGFP) larvae were crushed and cell suspen-
sions were homogenized in ice-cold 0.9× phosphate-
buffered saline (PBS) containing 5 % fetal bovine serum,
and then passed through a 40 μm filter to obtain a single
cell suspension. These single cells treated with red blood
cell lysis solution and washed once with PBS, stained
with Propidium Iodide (Sigma-Aldrich) at a final con-
centration of 1 μg/mL and analyzed by fluorescence-
activated cell sorting (BD FACS ARIA II SORP, USA) to
investigate apoptosis in RUNX1-Evi-1 positive cells.
Statistical analysis
Data were analyzed on GraphPad Prism 5 using one-way
ANOVA and unpaired Student’s t test. Differences were
considered significant at p values of less than 0.05.
Results
Establishment of Tg(RE:HSE:EGFP) zebrafish line
About 40 % of the embryos injected with the pSGH2-
RUNX1-Evi-1 plasmid exhibited EGFP+ expression after
heat shock at 38°Cfor an hour. The adult EGFP+ fish
was crossed with the WT fish. The Tg(RE:HSE:EGFP) F0
founders with the highest germline transmission rate
were identified on the basis of fin genotyping (Fig. 2c-d)
and EGFP expression of the F1 offspring after the same
heat shock treatment. Three of 146 (2.1 %) mosaic F0
zebrafish were identified as the stable germline Tg zebra-
fish, including 2 males and 1 female. The Tg F1 generation
Table 1 RT-PCR Primers
Name Forward primer Reverse primer Product (bp)
RUNX1-Evi-1 ATATCGCTGCGAAGACTGTGACCA TGAAGGTTGCTAGGGTCCGTGAAA 381
scl GAACAGTATGGGATGTATCCTAGC CGTTGAGGAGCTTAGCCAGA 265
lmo2 ACACTGGAGGCAAATGAGGAG AGTAAAGCCTGCGTCCCACC 193
gata2 CTGCCAGACAACCACGACC CCAGATCGTTTACTCCTCTTGG 180
gata1 CCATCGTATTATTCCACCAGC GGATGTGGGGTTGTAGGGAG 159
pu.1 TCCCAGCAGTCGTAGTCCTC CCATTTCGCAGAAGGTCAA 141
mpo GGGTTGACCACGATCTGACT CAGGGAGACAGGTGTTAGGG 159
c-myb GGCAGAAAGTCCTCAACCC ATCGGTTTCCAAGTTTCTCG 252
runx1 TGGGACGCCAAATACGAAC AGGACGGAGCAGAGGAAGTT 227
P21 GAACGATGTGCTGCACTCCC TGTCAATAACGCTGCTACGAGAC 236
P27 CGACTGTAGGGTAACGGAGCA GGGTGTCGGACTCAATGGTT 178
P53 CGGCGATCATGGATTTAGGC TTCAGCCACATGCTCGGACT 202
ras GTCCACGATGAATCCCGAATA TCTCCTGCCCTGCTGTATCC 212
Bax ACAGGGATGCTGAAGTGACC GAAAAGCGCCACAACTCTTC 236
Bcl2 AACGCGAATTTGAGGAAATG TATCTACCTGGGACGCCATC 189
JNK AACAGGAATAAGCGCGAGAA TTGTGGTTGACGCATTTCAT 245
JUN AAACAGCGCTTTCTCTCAGC TGATCATGCCGTTGCTAGAC 221
skp2 ATCTGGGACTGAGCCGTTGT GAGAACGGCTGCGTGTTGAT 166
Caspas3 AGGCTTGTCGAGGAACAGAA CATGATCTGCAAGAGCTCCA 233
smad7 GGTTCTGTGCCTGCTTCCA TGCCCTGAGGTAGGTCGTAGA 202
smad4 AGACCTCCACATACCACCACA GTCCATCTCGAAGTAGGCAAT 221
β-actin CCTGACCGAGAGAGGCTACA CGCAAGATTCCATACCCAAG 242
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were mated to create homozygous Tg(RE:HSE:EGFP) line.
The EGFP+ frequency of F2 offspring reached to 75 %
after heat shocked.
RUNX1-Evi-1 induced immature hematopoietic cells
emerged in blood circulation
Using Wright Giemsa staining, peripheral blood from
WT zebrafish at 60 dpf contained clusters of erythro-
cytes, while myeloid cells were only occasionally observed
(Fig. 3a). In contrast, the blood cells from the Tg(RE:H-
SE:EGFP) fish contained some blast-like cells, which were
larger than the erythrocytes and had high nuclear to cyto-
plasmic ratios with multiple large nucleoli. These cells re-
sembled to human AML blasts. Meanwhile, erythrocytes
were significantly inhibited (Fig. 3b). The similar feature
presented in single cell suspensions of kidney from WT
and Tg F2 generation (Fig. 2c-d).
RUNX1-Evi-1 reprogrammed lineage-specific
hematopoietic transcription factors
Similar to mammalian, zebrafish also experienced a primi-
tive wave and a definitive wave of hematopoiesis. From
the 2 somite stage, cells co-expressing stem cells transcrip-
tion factor (scl), gata2 and LIM only protein 2 (lmo2)
transcription factors bilaterally appeared in both the anter-
ior lateral mesoderm (ALM) and the posterior lateral
mesoderm (PLM). They have the potential to become
HSCs, but not kidney progenitors [20]. The expression of
scl, lmo2, and gata2 were measured by qRT-PCR and in
situ hybridization in WT and Tg(RE:HSE:EGFP) F2 gener-
ation embryos at 12hpf, 18hpf and 24 hpf. Scl was slight
higher expression in Tg embryos than that in WTat 24hpf
(0.329 ± 0.066 vs 0.547 ± 0.096, P = 0.032) (Fig. 4a, i-j). No
significant difference of lmo2 expression between WT and
Tg(RE:HSE:EGFP) zebrafish was identified (Fig. 4b, k-l).
Gata2 was upregulated compared to WT counterpart at
18 hpf (1.180 ± 0.075 vs 1.426 ± 0.066, P = 0.013) and 24 hpf
(1.211 ± 0.045 vs 1.965 ± 0.144, P = 0.001) (Fig. 4c, m-n).
Gata1 and pu.1 is the master regulator in erythrocyte
and myeloid cell development involved in primitive he-
matopoiesis, respectively. In zebrafish, gata1 is expressed
from the 5 somite stage in the PLM. According to the
results in WT and Tg embryos at 1 dpf (1.114 ± 0.126 vs
0.493 ± 0.097), 3 dpf (1.674 ± 0.237 vs 1.308 ± 0.236), 7
dpf (2.565 ± 0.321 vs 1.863 ± 0.192), and 60 dpf (5.496 ±
0.470 vs 2.573 ± 0.328). It was demonstrated that the
levels of gata1 significantly decreased in Tg embryos
(Fig. 4d, o-p). Pu.1 is expressed from the 6 somite stage
in the ALM. Compared with WT, its expression was up-
regulated in Tg groups at 3 dpf (1.274 ± 0.165 vs 1.702 ±
0.155) and 7 dpf (2.432 ± 0.540 vs 3.496 ± 0.367) (Fig. 4e).
Like in mammals, the first definitive HSCs of zebrafish
arise from the ventral region of the dorsal aorta, and
express runx1 and c-myb transcription factors. Unlike
primitive HSCs, definitive HSCs have the potential to
become all blood lineages including lymphocytes. Runx1
Fig. 3 Cytological analysis of Tg(RE:HSE:EGFP) zebrafish. Cytology of hematopoietic cells from WT (a) and Tg(RE:HSE:EGFP) F2 generation (b)
zebrafish at 60 dpf. The blood cells from WT fish were predominantly erythrocytes, and by contrast, erythrocytes were significantly inhibited in
Tg(RE:HSE:EGFP) fish, enriched for abundant blast-like cells, which are larger than the erythrocytes and have high nuclear to cytoplasmic ratios,
containing multiple large nucleoli (black arrow). These blasts were similar to that of human AML peripheral blood. The similar feature presented
in single cell suspensions of kidneys from WT (c) and Tg F2 generation (d)
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were dramatically downregulated in Tg(RE:HSE:EGFP)
embryos at 1 dpf (1.114 ± 0.156 vs 0.393 ± 0.099), 3 dpf
(5.474 ± 0.402 vs 1.256 ± 0.296), 7 dpf (4.765 ± 0.892 vs
1.996 ± 0.470), and 60 dpf (3.496 ± 0.470 vs 1.609 ± 0.274)
(Fig. 4g). Whereas, the expression of c-myb, whose ex-
pression is predominantly present in immature hemato-
poietic cells and decreases during cell differentiation, did
not decrease with cell growth and differentiation in
Tg fish at 60 dpf (0.314 ± 0.158 vs 4.122 ± 0.419, P = 0.000)
(Fig. 4h). It was indicative of a large number of immature
blood cells accumulating in blood circulation.
As the downstream gene of pu.1, myeloperoxidase
(mpo) was the granulocyte specific gene and considered
as the symbol of mature neutrophils, whose expression
was firstly detected in between 18 and 20 hpf with the
distribution from the intermediate cell mass (ICM) to
rostral blood island (RBI). In Tg fish, the mpo expression
obviously reduced at 3 dpf (1.474 ± 0.402 vs 0.753 ±
0.158), 7 dpf (3.199 ± 0.373 vs 2.029 ± 0.173), and 60 dpf
(4.496 ± 0.470 vs 2.576 ± 0.325) (Fig. 4f, q-r). It’s not
enough to support the myeloid cells’ further develop-
ment and differentiation.
RUNX1-Evi-1 changed multiple transcriptional pathways
in transgenic larvae
Using Agilent microarray analysis, we obtained a total of
578 DEGs in the blood cells of Tg(RE:HSE:EGFP) F2
generation vs WT larvae at 3dpf. There were 348 genes
upregulated and 230 genes downregulated (2-fold change
in expression, P < 0.01). Analyzed by NIH-DAVID
Fig. 4 RUNX1-Evi-1 reprogrammed lineage-specific hematopoietic transcription factors. Scl (a), lmo2 (b) and gata2 (c) were detected by qRT-PCR
in WT, and Tg(RE:HSE:EGFP) F2 generation embryos at 12 hpf, 18 hpf and 24 hpf. Gata1 (d), pu.1 (e), mpo (f), runx1(g), and c-myb (h) expressed in
WT, Tg F2 zebrafish at 1 dpf, 3 dpf, 7 dpf and 60 dpf. Compared with WT, scl, gata2, pu.1, and c-myb were up-regulated, while gata1, mpo, and
runx1 were down-regulated in Tg fish. In situ hybridization of scl (i-j), lmo2 (k-l), gata2 (m-n), and gata1 (o-p) at 24hpf and mpo (q-r) at 30hpf in
WT and Tg F2 embryos demonstrated the same tendency. *P < 0.05; **P < 0.01
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software, several KEGG pathways were significantly en-
riched (P < 0.01, Benjamini < 0.01) (Table 2) (GSE74944).
Some signaling pathways were upregulated in the
Tg(RE:HSE:EGFP) fish, including proteasome, cell cycle,
glycolysis/gluconeogenesis, tyrosine metabolism, trypto-
phan metabolism, metabolism of xenobiotics by cyto-
chrome P450, PPAR signaling pathway, etc. Glycolysis
was often depended on for ATP production in rapidly
proliferating tumors even in normoxia, which is defined
as the Warburg effect. Here, RUNX1-Evi-1 also signifi-
cantly upregulated the genes that correlated with glycoly-
sis/gluconeogenesis (n = 16, P = 8.5E-6), including fructose-
1, 6-bisphosphatase I, glucose-6-phosphate 1-epimerase,
and glucose-6-phosphate isomerase.
Meanwhile, transforming growth factor β (TGFβ), Jak-
STAT, DNA replication, mismatch repair, p53 pathway,
JUN N-terminal kinase (JNK) signaling pathway, nucleo-
tide excision repair were downregulated. JNKs belong to
the superfamily of mitogen-activated protein kinases that
are involved in the regulation of cell proliferation, differ-
entiation and apoptosis [21]. Compared with WT, some
crucial genes were downregulated in Tg samples (n = 7,
P = 6.8E-4, Fig. 5). The proteins of JNKs and p-JNKs (the
activated state) dramatically decreased in Tg(RE:H-
SE:EGFP) F2 larvae (Fig. 5).
Majority of the above pathway alterations were associ-
ated with human hematopoietic disorders and malignant
transformation of blood cells [22–26]. These data needs
to be verified in further experiments.
VPA partially rescued some pathways abnormally
regulated by RUNX1-Evi-1
Mitani found that RUNX1-related chimeras generated
by the chromosomal translocations repress transcriptional
activity of wild-type RUNX1 (AML1) by recruiting the co-
repressor/histone deacetylase complex in leukemia cell
lines. Further, as a histone deacetylase inhibitors(HDACi),
VPA could elicit apoptosis through both extrinsic and
intrinsic pathways in these cells [27]. Here, microarray
analysis also showed that histone deacetylase 4 (hdac4)
was significantly upregulated in Tg(RE:HSE:EGFP) F2 gen-
eration larvae (6.18 vs 10.62, fold change: 21.70, showed in
Table 3). Therefore, we investigated the in vivo effects of
VPA on Tg(RE:HSE:EGFP) zebrafish.
Table 2 Change of signaling pathways in Tg(RE:HSE:EGFP) zebrafish
Term Regulate Counta %b P-Value Benjamini
Proteasome + 11 1.3 2.6E-9 2.8E-7
Cell cycle + 28 2.2 5.3E-8 3.7E-6
Glycolysis/Gluconeogenesis + 16 1.0 8.5E-6 7.0E-5
Tyrosine metabolism + 10 0.9 9.1E-6 3.9E-5
Tryptophan metabolism + 8 0.9 1.6E-5 4.1E-4
Drug metabolism + 7 0.8 5.1E-5 7.6E-3
Metabolism of xenobiotics by cytochrome P450 + 7 0.8 5.1E-3 7.6E-2
Androgen and estrogen metabolism + 8 0.9 7.0E-3 8.0E-2
PPAR signaling pathway + 6 0.7 7.2E-3 7.4E-2
Retinol metabolism + 4 0.5 8.4E-3 7.5E-2
Jak-STAT signaling pathway - 14 2.4 6.8E-10 8.3E-8
DNA replication - 15 1.1 3.5E-9 3.0E-7
Mismatch repair - 8 0.9 4.5E-7 1.8E-6
Homologous recombination - 12 0.9 8.9E-7 3.5E-5
Base excision repair - 12 1 2.7E-6 4.7E-5
Spliceosome - 22 1.6 2.9E-5 4.4E-4
Nucleotide excision repair - 18 1.2 6.3E-5 4.3E-4
p53 signaling pathway - 16 1.3 3.8E-4 8.3E-3
JNK signaling pathway - 7 1.2 4.0E-4 8.7E-3
Butanoate metabolism - 4 0.7 4.1E-4 2.7E-3
Transforming growth factor β - 14 1.1 6.3 E-4 7.3 E-3
Porphyrin and chlorophyll metabolism - 4 0.7 7.4E-4 7.8E-3
Arginine and proline metabolism - 5 0.9 7.8E-4 8.0E-3
+: upregulated; −: downregulated. a: genes involved in the term. b: involved genes/total genes
P-Value: the threshold of EASE Score, a modified Fisher Exact P-Value, for gene-enrichment analysis (<0.01). Benjamini: Benjamini and Hochberg’s false discovery
rate (<0.01)
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Tg(RE:HSE:EGFP) embryos were treated with different
concentrations of VPA at 28 °C from 14 hpf after one
hour of heat shock treatment. According to the outcome
at 72hpf [Y = 29.18ln(x) + 0.49 (0.9799)], we got the
LD50 as 69.72 μM, and chose 35 μM, 70 μM to carry on
detecting the effectiveness. By FCM analysis, elevated
apoptosis was presented in VPA treated groups, which
was indicated by sub G1 peak. Compared with the un-
treated group, treated with 70 μM VPA induced apoptosis
at (60.43 ± 7.28) % and decreased S/G2 cell population at
[(87.37 ± 4.06) % vs (23.64 ± 3.23) %, P < 0.01], correspond-
ingly, G1 arrest was increased.
Furthermore, we measured the expression of some
crucial factors involved in proliferation and apoptosis
pathways after treated with different concentrations of
VPA by qRT-PCR (Fig. 7). It showed that VPA reduced
the expression of skp2 and upregulated p21, p27, which
would inhibit the progress of cell proliferation. Smad7
was also inhibited by VPA and revived the TGF β signal-
ing. VPA significantly downregulated Bcl2, but enhanced
the expression of P53, Bax, JNK and JUN, which indicated
the activation of both extrinsic and intrinsic apoptosis.
Majority change of these genes was concentration de-
pendence (Fig. 7). In contrast, the expression of the above
genes showed no significant difference in wild type zebra-
fish embryos treated with the similar dose of VPA (data
not shown).
Followed-up of the transgenic zebrafish
Different from 3 years lifetime of the WT zebrafish, all
these three F0 founders died within 8–14 months (me-
dian: 10.6 months). Most of the F1 and F2 generation
gradually lost the EGFP expression and the ability of fe-
cundity, and began to die older than 12 months. Along
with the growth of Tg(RE:HSE:EGFP) zebrafish, some of
them presented pathological appearance (e.g. hemorrhage,
edema and small size) (Fig. 8).
Table 3 RUNX1-Evi-1 upregulated histone deacetylase in
microarray analysis
Genes WT AE-F2 FC Regulation
Histone deacetylase 11 (HD11) 5.47 8.16 6.49 +
Histone deacetylase 4 (hdac4) 6.18 10.62 21.70 +
H1 histone family, member X (h1fx) 10.02 11.36 2.53 +
FC: fold change; +: upregulated
Fig. 5 DEGs involved in JNK pathway in Tg(RE:HSE:EGFP). Using Agilent microarray analysis, compared with WT at 3dpf, it showed that RUNX1-Evi-1
could down-regulate some crucial genes in JNK pathway, including c-JUN, ATF-2, Elk-1, and GADD153. MKK7 is a functional gene in MAPK pathway,
which was also down-regulated in this model. The signaling pathways were analyzed and summarized by NIH-DAVID software (in KEGG) and the
differentially expressed genes were marked with red star in the automatically generated figure. Western blot was further confirmed that JNK and
cleaved p-JNK expression were inhibited in Tg(RE:HSE:EGFP) F2 generation
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Discussion
Growing evidences demonstrated that normal function
loss of Runx1/AML1 or abnormal activation of Evi-1
was an indicator of poor prognosis in leukemia [27–29].
It was also shared that RUNX1-Evi-1 fusion gene could
enhance the malignant effectiveness [30]. Nevertheless,
the major mechanism of RUNX1-Evi-1 exerts in acute
leukemia and whether it possesses the whole role of Evi-
1 remained widely unknown. We reported here an
RUNX1-Evi-1 transgenic zebrafish model with a pheno-
type that recapitulated main aspects of human AML
such as distorted proliferation, anti-apoptosis, anemia,
increased immature myeloid cells and their precursors
accumulated in peripheral circulation and kidney marrow
(kidney marrow serves throughout the life of a zebrafish,
generating adult hematopoietic cells, just like human’s
Fig. 6 VPA promoted the G1 arrest and apoptosis in RUNX1-Evi-1 positive cells. The cells of Tg(RE:HSE:EGFP) embryos were sorted with GFP after
two days treated by 70 μM VPA. The ratio of S/G2 phase was sharply decreased (94.81 % vs 20.82 %), accompanied with a sub-G1 peak (61.37 %)
Shen et al. BMC Cancer  (2015) 15:970 Page 9 of 13
bone marrow [20]), which suggested that RUNX1-Evi-1
played a role in the etiology of AML. More importantly,
zebrafish offers the advantage of high-throughput scale in
the study of RUNX1-Evi-1 function and drug screen
in vivo, which enables us to track the molecular alterations
that occur well before the appearance of morphological
phenotypes, and to determine the roles of candidate
RUNX1-Evi-1 target genes.
HSP has no tissue-specific preference, yet heat stress
exhibits more direct and far-reaching influence on white
blood cells than other cells. Moreover, RUNX1-Evi-1
overexpression is highly oncogenic in myeloid cells.
Thus, the establishment of RUNX1-Evi-1 transgenic zeb-
rafish with the uniform phenotype of the tumor cells
shows better resemblance to the feature of human
MDS/AML.
Carolyn [28] found disruption of terminal myeloid dif-
ferentiation and cell cycle regulation to be prominent in
Evi-1-induced leukemogenesis. Using microarray ana-
lysis, we also found the upregulation of cell cycle (n = 28,
P = 5.3E-8) and repression of TGF-β signaling (n = 14,
P = 6.3 E-4) in Tg(RE:HSE:EGFP) zebrafish, accompanied
by increased expression of some early hematopoiesis tran-
scription factors (gata2 and pu.1) (Fig. 4c, e, m-n). Gata2
was a zinc finger transcription factor which was required
for proliferation and maintenance of hematopoietic pro-
genitor cells [20]. Yuasa [31] showed that Evi-1 promoted
early hematopoietic development in the P-Sp region,
which seemed to depend on activation of gata2 and re-
pression of TGF-β signaling, while ZF1 of Evi-1 directly
recognized and banded to the gata2 promoter. Gata2 has
been reported to be aberrantly expressed in 87 % of de
novo AML cases while well correlation between Evi-1 and
gata2 expression were found in AML patients [28, 32].
Thus, it’s feasible that gata2 plays a crucial role in
RUNX1-Evi-1 or Evi-1-induced leukemogenesis. Likewise,
Evi-1 interacted with pu.1 and repressed the pu.1-
dependent activation of a myeloid promoter [21]. Leo-
poldo [21] reported on a mouse model that constitutive
expression of Evi-1 in the BM led to fatal anemia and
myeloid dysplasia, and Evi-1 interaction with gata1 blocks
proper erythropoiesis. Here, RUNX1-Evi-1 slightly en-
hanced the expression of pu.1, but repressed the level of
mpo, the downstream regulator of pu.1 (Fig. 4e-f, q-r).
Fig. 7 VPA changed some genes expression in Tg(RE:HSE:EGFP) embryos. VPA reduced the expression of skp2 and smad7, and upregulated p21
and p27, which inhibited the progress of cell proliferation. VPA significantly downregulated Bcl2, and meanwhile enhanced the expression of P53,
Bax, JNK and JUN. Majority of these changes were concentration dependence. *P <0.05; **P < 0.01
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Meanwhile, gata1, the indispensable promoter for erythro-
poiesis, was overwhelmingly inhibited along with growth
(Fig. 4d, o-p). Actually, there was a cross-inhibitory mech-
anism between the expression of gata1 and pu.1 in zebra-
fish [20], which indicated that the level of pu.1 expression
was determined by the ability of RUNX1-Evi-1 to regulate
both pu.1 and gata1, thus increased the repopulation of
immature myeloid cells and anemia.
Evi-1 was a zinc finger-containing and site specific
DNA-binding transcription factor, but it did not seem to
inhibit pu.1 binding to DNA, but rather to block its as-
sociation with the co-activator JNK and its substrates
[21]. In response to cell death stimuli, p-JNKs activated
apoptotic signaling by regulating apoptotic-associated
genes via the transcriptional activation of specific tran-
scription factors or by directly modulating the activities
of mitochondrial apoptosis-associated proteins through
distinct phosphorylation events [24]. In our previous
work, we demonstrated that arsenic trioxide (ATO)
could reactivate apoptosis in the THP1 (with high level
of Evi-1 expression) cell line by downregulating Evi-1.
ATO significantly decreased Bcl-2 and Bcl-xL expres-
sion, thus accordingly increased the levels of JNK, p-
JNK, Bax, full length caspase-3 and cleaved caspase-3 in
western blot analysis [33]. In the present study, RUNX1-
Evi-1 fusion gene inhibited both JNK signaling and P53
pathway (Table 2). Using FCM, we found that more than
50 % of RUNX1-Evi-1 positive cells were in the S/G2
period and no sub-G1 peak (Fig. 6), which demonstrate
apoptosis resistant and weak efficacy of G1 arrest. Be-
cause of the deficiency of enough monoclonal antibody
for zebrafish and lethal effectiveness of RUNX1-Evi-1 to
mouse embryos [34], we plan to do further study on the
efficacy of ATO in Tg(RE:HSE:EGFP) zebrafish and con-
firm molecular mechanism in detail through retroviral
transduction of RUNX1-Evi-1 into Evi-1 negative cell
lines or adult mice.
RUNX1-related chimeras generated by the chromo-
somal translocations repressed transcriptional activity of
wild-type RUNX1 by recruiting the co-repressor/histone
deacetylase complex [27]. Thus, histone deacetylase in-
hibitors were expected to restore normal functions of
wild-type RUNX1, and thereby affect the growth and dif-
ferentiation ability of leukemic cells expressing the
chimera. Histone deacetylase 4 obiously increased in
Tg(RE:HSE:EGFP) larvae (Table 3). Therefore, we inves-
tigated the in vivo effects of histone deacetylase inhibitor
(VPA). G1 arrest and apoptosis progression were sig-
nificantly enhanced in RUNX1-Evi-1 positive cells after
2-day treated with VPA (Fig. 6). Up- and downregulation
of cell cycle and apoptosis regulator genes appeared to
be the molecular basis for the former (Fig. 7). Therefore,
VPA may be an attractive choice in the molecular target-
ing therapy of RUNX1-Evi-1-related leukemia.
60 years ago, some scholars have presented that disor-
dered amino acid metabolic processes in patients with
acute leukemia, such as eighteen patients with acute
leukemia averaged 137.1 mg. of urinary “tyrosyl” in
24 hr. as compared to 115.8 mg. for normal individuals
of the same age group [35]. Tyrosine kinase inhibitors
(TKIs) therapy in leukemia cells creates a novel metabolic
state that is highly sensitive to particular mitochondrial
perturbations [36]. The essential amino acid L-tryptophan
(L-TRP) is required for the biosynthesis of proteins and is
precursor for several biologically important compounds,
and the inhibition level of L-TRP metabolites in blood
could be a useful parameter of chemotherapy efficacy for
Adult T-cell Leukemia/Lymphoma patients [37]. In con-
trary, the majority of newly diagnosed AML patients’
blasts have deficiencies in the arginine-recycling pathway
enzymes argininosuccinate synthase and ornithine trans-
carbamylase, making them arginine auxotrophic [38].
Miraki-Moud F et al. showed that AML cells from most
patients with AML are deficient in a critical enzyme
required for arginine synthesis, arginino succinate
synthetase-1 (ASS1). Thus, these ASS1-deficient AML
cells are dependent on importing extracellular arginine
[39]. Using Agilent microarray analysis, we also found that
tyrosine metabolism and tryptophan metabolism pathway
were upregulated, while Arginine and proline metabolism
Fig. 8 The appearance changes in Tg(RE:HSE:EGFP) adult zebrafish.
(a) WT AB strain zebrafish; (b-d) various appearances with pathological
changes presented in transgenic zebrafish, developmental delay (b),
edema (c), and bleeding (d)
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were inhibited in the Tg(RE:HSE:EGFP) F2 generation. It
suggested that the strategy of enzymatic degradation of
amino acids to deprive malignant cells of important nutri-
ents would be an established component of induction
therapy of AML.
Interestingly, Maki [34] knocked-in the RUNX1-Evi-1
chimeric gene into mouse embryo, which led to defective
hematopoiesis in the fetal liver and death around embry-
onic day 13.5 (E13.5) as a result of hemorrhage in the cen-
tral nervous system. Maki hypothesized that maintained
expression of pu.1 gene and decreased expression of lmo2
and scl genes may explain the aberrant hematopoiesis. We
also found that some of the Tg(RE:HSE:EGFP) zebrafish
died of hemorrhage (Fig. 8d). However, the levels of scl
and lmo2 expression were similar to those in WTcounter-
part and the average lifespan was nearly 12 months. Tak-
ing the advantage of transparence in zebrafish embryo, we
performed whole-mount in situ hybridization to confirm
the difference expression of these factors, which were con-
sistent with the results of qRT-PCR. The different out-
come between Maki’s and ours may be associated with the
different species, which needs further explore.
Conclusion
Taken together, the phenotypes of Tg(RE:HSE:EGFP) fish
resemble to those of the human’s MDS-RAEB or AML.
RUNX1-Evi-1 promoted the primitive hematopoietic cell
proliferation and apoptosis resistant, inhibited myeloid
cells differentiation through synergy of several pathway
and factors. This model provides a useful tool to con-
duct whole-organism chemical suppressor screens to
identify compounds that can regain RUNX1 function
and reverse Evi-1 in vivo. We propose VPA to be an at-
tractive choice in the molecular targeting therapy of
RUNX1-Evi-1-related leukemia.
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